Dr. Jess Silva-Fisher

Snowy scenery

Good Morning ❄️❄️🌨️

Sometimes the best #labmeetings are over ☕. #SilvaFisherlab #cancerresearch 😜

The #MCEDAct hit 400 cosponsors today!

As the most-supported bill in Congress, there's overwhelming bipartisan support to get this important legislation over the finish line. 💪

If passed, it could help innovative cancer #EarlyDetection tests reach more people who need them.

At UMass Chan, where Nobel Laureates pioneered small RNA discoveries, we empower the next RNA GIANTS

OPEN FOR GRAD APPLICATIONS!! The NEW RNA Therapeutics & Biology Program in the Basic Biomedical Sciences PhD program develops leaders. Register for the workshop to get qs answered ahead of Dec 1, 2025 app deadline.
Admission Workshop Tues, Nov 18, 2025: direc.to/nA7S

Great day for a 5k 🏃‍♀️ @lungcancerconnect.bsky.social #RunWalkBreathe #lungcancer @sitemancenter.bsky.social
@washumedicine.bsky.social #SilvaFisherlab

📢 FINAL CALL! Don't miss your chance to apply for ASH CHAMP—a year-long opportunity to be paired with an expert mentor in classical hematology.

🔗https://ow.ly/fLYQ50Xjb19

#HemeSky #HemeOnc #MedSky

Check how this study highlights LINC01432 as a potential therapeutic target for overcoming resistance in high-risk multiple myeloma.

"Investigation of lncRNA expression in newly diagnosed multiple myeloma reveals a LINC01432-CELF2 axis as an inhibitor of apoptosis"

🔵 Jessica Silva-Fisher latest and outstanding research is now available to read in #Oncogenesis.

▶️ Read the open access article here: www.nature.com/articles/s41...

#SilvaFisherlab Halloween pics 🎃

Say Hi to Luna! #Frenchie

Nicklaus: With $115 million in hand, biotech startup eyes the finish line Wugen has become a standout among St. Louis biotech startups. It has raised more than $300 million in capital since 2018 and employs about 35 people.

Named one of St. Louis’ most exciting startups to watch in
@stltoday.com, Wugen is redefining the future of cancer care. The WashU-born biotech standout recently raised $115M to advance a modified cell-based therapy found to work in 91% of patients. www.stltoday.com/news/local/b...

#BehindThePaper learn more about our recent paper! @springernature.com
#SilvaFisherlab @sitemancenter.bsky.social @washumedicine.bsky.social
communities.springernature.com/posts/unlock...

Biological Laboratory | LEGO® Ideas This is a two-floor realistic Biological Laboratory building. In this design, I try to tell stories about biologists, introduce biology concepts to general publ…

I just made an account and voted for this biology laboratory made of LEGO to "promote biological research and inspire more people into the world of biology". They need 10K votes. Reposting and/or voting below would be helpful. 🤗
beta.ideas.lego.com/product-idea...

Please nominate or apply for an RNA Society Award by October 20th!
www.rnasociety.org/awards

Thank you to @uarizona.bsky.social 2025 Joint Biology Retreat Graduate Student Committee for inviting me to be their Keynote Speaker!Amazing time learning about the innovative research being led by grad students and new faculty. Speaking at #Biosphere2 was truly a historic experience.#SilvaFisherlab

@washumedicine.bsky.social @sitemancenter.bsky.social @oncogenesisnature.bsky.social @ash.hematology.org

Investigation of lncRNA expression in newly diagnosed multiple myeloma reveals a LINC01432-CELF2 axis as an inhibitor of apoptosis - Oncogenesis Multiple myeloma (MM) is an incurable malignancy of plasma cells, with over 35,000 new cases diagnosed annually in the United States. Despite an expanding arsenal of approved therapies, nearly all pat...

Thrilled to share our new paper! 🧬 link.springer.com/article/10.1...

We show how this lncRNA–protein interaction impacts cell survival in #multiplemyeloma.

Huge thanks to all co-authors and especially the students for their incredible work! 🙌
#SilvaFisherlab #RNA #lncRNA

Your research on hematologic diseases and disorders that disproportionately affect vulnerable communities is too vital to be threatened by federal funding cuts!

The ASH Treating Fairly Research Award supports researchers now. Apply: https://ow.ly/PIwH50Xb9mX #Fight4Hematology #Hemesky #Medsky

Save the Date for RNA 2026 in Montreal, Canada!

Since 2012, the ASH Bridge Grant has funded 205 researchers with $28M, leading to $680M in follow-on NIH funding. These grants keep labs running and fuel breakthroughs in hematology. Learn more: https://bit.ly/48yINrB

🔗: medicine.washu.edu/news/washu-m... WashU Medicine’s innovative fellow-to-faculty programs — including RISE, Cori, and Dean’s fellows— are attracting sought-after postdoctoral talent for their unique opportunities, which help accelerate career advancement into professorship.

RNA journal Call for Papers on RNA-based Therapeutics, Diagnostics, and Disease!

ASH CHAMP is now accepting applications! This unique year-long program connects trainees with expert mentors in classical hematology—especially helpful if your institution lacks robust mentorship in this area.

🔗Apply today: https://bit.ly/46D9AAb

#HemeSky #HemeOnc #MedSky

#Charcuterie Friday!

Joining #PedalTheCause virtually! 🚴‍♀️ Not a big biker, so I’ll be running instead 🏃‍♀️

Running for my mom + dad 💪 (survivors) and in memory of my grandma + grandfather in-law +cousin 💛

Let’s push for a world without cancer. 🌍✨ #CancerResearch #EndCancer
@sitemancenter.bsky.social #SilvaFisherlab

Applications are now open for ASH trainee awards! Whether you’re a medical student, resident, or hematologist, these awards provide mentorship, funding, research opportunities, and more.

Apply today and take your next big step: https://bit.ly/4mFbcAc

#ASHAwards #HemeSky

Women are constrained by gender stereotypes in leadership roles - UGA Today A new UGA study reveals the destructive effects of gender norms and expectations for female bosses and how it affects their ability to lead.

Study finds when women bosses were more assertive, thus deviating from gender norms, they felt depleted, incompetent, anxious, overwhelmed & more withdrawn. But men didn't experience stress over gender expectations, whether they were kind or stern.
news.uga.edu/women-constr...

Every clinician benefits from the right mentor.

The new ASH Malignant Hematology Mentorship Program is now open for applications—offering fellows a chance to build lasting connections, receive career guidance, and grow within malignant hematology.

🔗 https://bit.ly/3IPWjMA

Application for 2025/2026 RNA Salons is now open. Please apply by 31st August to receive support your local or regional RNA activities. @rnasociety.bsky.social #Lexogen www.rnasociety.org/salons

🎥 Share your story to help protect cancer research funding. If you've been impacted by advancements in cancer research or recent cuts to clinical trials, we want to hear from you.

Every cancer research breakthrough leads to stories. Stories of strength. Stories of hope.

Congress needs to understand that cancer research funding isn’t just about numbers or budgets—it’s about people.

If you’ve been impacted by cancer, share your story to help show #CancerResearch saves lives.